APA

Gonzalez-Gay M. A., Vazquez-Rodriguez T. R., Garcia-Unzueta M. T., Berja A., Miranda-Filloy J. A., de Matias J. M., Gonzalez-Juanatey C. & Llorca J. (20100507). Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy. : Clinical and experimental rheumatology.

Chicago

Gonzalez-Gay M A, Vazquez-Rodriguez T R, Garcia-Unzueta M T, Berja A, Miranda-Filloy J A, de Matias J M, Gonzalez-Juanatey C and Llorca J. 20100507. Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy. : Clinical and experimental rheumatology.

Harvard

Gonzalez-Gay M. A., Vazquez-Rodriguez T. R., Garcia-Unzueta M. T., Berja A., Miranda-Filloy J. A., de Matias J. M., Gonzalez-Juanatey C. and Llorca J. (20100507). Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy. : Clinical and experimental rheumatology.

MLA

Gonzalez-Gay M A, Vazquez-Rodriguez T R, Garcia-Unzueta M T, Berja A, Miranda-Filloy J A, de Matias J M, Gonzalez-Juanatey C and Llorca J. Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy. : Clinical and experimental rheumatology. 20100507.